News
Chikungunya Virus Outbreak in China: Key Facts, Prevention, and Vaccination Guidelines
Table of Contents
Chikungunya Virus Spreads in Guangdong Province, China – What You Need to Know
Health officials in China have reported an outbreak of the chikungunya virus in Guangdong Province, with most cases concentrated in Foshan city. The disease, transmitted by infected mosquitoes, poses a significant public health risk, especially for travelers visiting affected regions.
How Does Chikungunya Spread?
The chikungunya virus is primarily spread through the bites of infected Aedes aegypti and Aedes albopictus mosquitoes, the same mosquitoes responsible for dengue and Zika viruses. These mosquitoes are most active during the day, particularly in the early morning and late afternoon.
Symptoms of Chikungunya Virus Infection
Common symptoms include:
- High fever
- Severe joint pain (often debilitating)
- Headache
- Muscle pain
- Joint swelling
- Rash
Symptoms typically appear 3–7 days after being bitten and can last for weeks or even months. While most people recover fully, some may experience persistent joint pain.
Who Is at Higher Risk?
- Pregnant women – Infection near delivery can transmit the virus to newborns, leading to severe complications.
- Newborns – Infants infected during or after birth are at risk of severe illness.
- Older adults (60+ years) – May experience more severe symptoms.
- People with chronic conditions – Such as hypertension, diabetes, or heart disease.
How to Protect Yourself from Chikungunya
Since there is no specific treatment for chikungunya virus, prevention is crucial. Follow these steps to avoid mosquito bites:
- Use EPA-approved insect repellent (containing DEET, picaridin, or oil of lemon eucalyptus).
- Wear long-sleeved shirts and pants to minimize skin exposure.
- Stay in air-conditioned or screened-in areas to keep mosquitoes out.
- Use mosquito nets if sleeping outdoors or in open areas.
- Eliminate standing water where mosquitoes breed (buckets, flower pots, etc.).
Chikungunya Vaccination for Travelers
Two vaccines are currently approved in the United States for chikungunya prevention:
- IXCHIQ (Live-attenuated vaccine) – Approved in November 2023 for adults 18+ years.
- VIMKUNYA (Virus-like particle vaccine) – Approved in February 2025 for adolescents and adults 12+ years.
Important Vaccine Safety Updates
Recent reports indicate potential risks for older adults receiving the IXCHIQ vaccine. The CDC and FDA are investigating cases of cardiac and neurologic events in individuals aged 60+ years. Until further studies are completed, the live-attenuated vaccine is not recommended for people over 60.
Travel Advice for Pregnant Women
Pregnant women should reconsider travel to areas with active chikungunya outbreaks, especially near delivery. If travel is unavoidable:
- Discuss vaccination risks and benefits with a healthcare provider.
- Take strict mosquito bite prevention measures.
When to Seek Medical Help
If you experience fever, joint pain, or rash during or after travel to an affected region, seek medical attention immediately. Early diagnosis can help manage symptoms and prevent complications.
Conclusion
The chikungunya virus outbreak in Guangdong, China, highlights the importance of mosquito bite prevention and vaccination for travelers. Stay informed, take precautions, and consult a healthcare provider before visiting affected areas.